Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
2012
1,275 citations
Journal Article
Field-Weighted Citation Impact:
124.03
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study | Researchclopedia
·
Memorial Sloan Kettering Cancer Center
Benjamin Solomon
·
Peter MacCallum Cancer Centre
Sai‐Hong Ignatius Ou
·
University of California, Irvine
Dong‐Wan Kim
·
Seoul National University
Ravi Salgia
·
University of Chicago
P. Fidias
·
Massachusetts General Hospital
Jeffrey A. Engelman
·
Massachusetts General Hospital
Leena Gandhi
·
Dana-Farber Cancer Institute
Pasi A. Jänne
·
Dana-Farber Cancer Institute
Daniel B. Costa
·
Beth Israel Deaconess Medical Center
Geoffrey I. Shapiro
·
Dana-Farber Cancer Institute
Patricia LoRusso
·
The Barbara Ann Karmanos Cancer Institute
Katherine Ruffner
·
Pfizer (United States)
Patricia Stephenson
·
Rho (United States)
Yiyun Tang
·
Pfizer (United States)
Keith D. Wilner
·
Pfizer (United States)
Jeffrey W. Clark
·
Massachusetts General Hospital
Alice T. Shaw
·
Massachusetts General Hospital